BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 6391406)

  • 1. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved results of renal transplantation in diabetic nephropathy.
    Wilczek H; Gunnarsson R; Lundgren G; Ost L
    Transplant Proc; 1984 Jun; 16(3):623-7. PubMed ID: 6375029
    [No Abstract]   [Full Text] [Related]  

  • 3. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical renal transplantation.
    Sommer BG; Ferguson RM; Najarian JS
    Urol Clin North Am; 1983 Feb; 10(1):149-59. PubMed ID: 6340311
    [No Abstract]   [Full Text] [Related]  

  • 6. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
    Rao KV; Andersen RC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal transplantation (second of two parts).
    Guttmann RD
    N Engl J Med; 1979 Nov; 301(19):1038-48. PubMed ID: 386122
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving results in primary diabetic renal transplantation.
    Zincke H; Engen DE; Sterioff S; McDonald MW; Frohnert PP; Johnson WJ
    Transplant Proc; 1984 Jun; 16(3):617-20. PubMed ID: 6375028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
    Sutherland DE; Fryd DS; Strand M; Ascher N; Simmons RL; Najarian JS
    Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current immunologic aspects of kidney transplantation].
    Lenhard V; Dreikorn K; Opelz G
    Urologe A; 1982 Sep; 21(5):280-9. PubMed ID: 6758280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 15. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal transplantation at the University of Wisconsin in the cyclosporine era.
    Knechtle SJ; Pirsch JD; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
    Clin Transpl; 1993; ():211-8. PubMed ID: 7918154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
    Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 19. Minnesota experience with 81 pancreas transplants since 1978.
    Sutherland DE; Chinn PL; Goetz FC; Elick BA; Najarian JS
    Transplant Proc; 1984 Jun; 16(3):695-703. PubMed ID: 6375036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
    Hourmant M; Soulillou JP
    Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.